600222.SHG Henan Taloph Pharmaceutical Stock Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
6.69 CNY
Close of Nov 5, 2026
6.30 9.44
Market cap
CNY 3.74B
P/E
74.3x
P/B
2.26x
ROE
1.3%
Dividend yield
1.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600222.SHG undervalued?

Graham number
Price6.69
Graham value2.45
Premium173.4%

600222.SHG trades 173.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Henan Taloph Pharmaceutical Stock Co Ltd fundamental analysis

No fundamental analysis for Henan Taloph Pharmaceutical Stock Co Ltd yet.

Henan Taloph Pharmaceutical Stock Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Henan Taloph Pharmaceutical Stock Co Ltd

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the manufacture and sale of pharmaceutical preparations and Chinese herbal medicine slices in China. The company offers Shuanghuanglian oral liquid series, Shuangjinlian mixture, children's heat-clearing and cough-relieving oral liquid series, pediatric antipyretic oral liquid, Jiaweishanxiang Zhengqi compound preparation, honeysuckle dew, danshen oral liquid, Shengmai Yin, pediatric compound chicken gizzard chewable table…

Full company profile